Best Microtubule Inhibitor for breast neoplasms
4 Microtubule Inhibitor drugs indicated for breast neoplasms, ranked by our independent rating. The current highest-rated is eribulin mesylate. Compare them with all treatments for breast neoplasms or the full Microtubule Inhibitor class. Not medical advice — always consult a professional.
Top microtubule inhibitor for breast neoplasms: 1. Eribulin Mesylate · 2. Halaven · 3. Taxotere
| # | Drug | Rating | Type | Typical price | |
|---|---|---|---|---|---|
| 1 | Eribulin Mesylate | Not yet rated | Prescription | — | View → |
| 2 | Halaven | Not yet rated | Prescription | — | View → |
| 3 | Taxotere | Not yet rated | Prescription | — |
Full ranking · 4 drugs
eribulin mesylate
PrescriptionFDA-sourced
Eribulin mesylate injection contains eribulin mesylate, a microtubule dynamics inhibitor.
microtubule inhibitorbreast neoplasmsliposarcoma
Price varies
Frequently asked
- What is the best microtubule inhibitor for breast neoplasms?
- By our independent rating, eribulin mesylate currently ranks highest among Microtubule Inhibitor drugs used for breast neoplasms. Ratings are based on FDA regulatory (recall-safety) data — always consult a professional.
- Which microtubule inhibitor drugs treat breast neoplasms?
- pharmaranks lists 4 Microtubule Inhibitor products indicated for breast neoplasms, per FDA drug-label data — each independently rated and ranked above.
- How are these ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
